RUOLO DELL'ANGIO-TC NELLA DIAGNOSI DI URGENZA DI ANGIODISPLASIA INTESTINALE ILEALE: UNA RARA CAUSA DI SANGUINAMENTO

2018

MASSE RENALI INCIDENTALI: DIAGNOSI DIFFERENZIALE IN ECOGRAFIA, TC E RM

2018

Systemic therapies for hepatocellular carcinoma: The present and the future

2021

Hepatocellular carcinoma is diagnosed in more than half of all cases at unresectable stage when no potentially curative treatments are feasible. Since 2008, sorafenib had represented the only effective first line systemic therapy over the last decade until the approval of lenvatinib, who showed to be non-inferior to sorafenib. Recently, for the first time, a combination of immunotherapy and antiangiogenic drug, atezolizumab plus bevacizumab, was associated with a significantly longer overall survival and progression free survival compared to sorafenib, becoming the new best performing first-line approach for unresectable HCC. After several randomized controlled trials (RCTs) that have attem…